GRACEcast

Emerging Options for T790M-Positive Acquired Resistance


Listen Later

Acquired resistance in EGFR patients is often driven by the T790M mutation. T790M-positive tumors respond differently to treatments than T790M-negative tumors. Dr. Greg Riely details how each status can predict patients' responses to current treatments.

...more
View all episodesView all episodes
Download on the App Store

GRACEcastBy Howard (Jack) West, MD